Keywords: b-ms, abatacept, shows, promise, rheumatoid, arthritis, phase

B-MS' abatacept shows promise for rheumatoid arthritis in Phase III trials

Article | 25 October 2004

Print This

New data from two Phase III trials presented at the American College of Rheumatology annual meeting in San Antonio, Texas, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in